JAMA Impact Factor 2026 – Publication Charge, Acceptance Rate, Review Time

JAMA (Journal of the American Medical Association) is the most widely circulated peer-reviewed general medical journal in the world. Founded in 1883 and published by the American Medical Association, JAMA publishes original research, reviews, and opinion pieces that influence medical practice, health policy, and clinical research across all medical disciplines. The journal’s commitment to improving public health through evidence-based medicine has made it one of the most cited and influential publications in medical science.

OVERVIEWJAMA Journal Overview

JAMA publishes original research, clinical reviews, special communications, and opinion pieces across the full spectrum of medical science. The journal covers all medical specialties including internal medicine, surgery, pediatrics, psychiatry, obstetrics and gynecology, oncology, cardiology, neurology, infectious diseases, public health, and health policy. JAMA maintains a rigorous peer-review process and editorial standards that have made it a benchmark for medical publishing worldwide.

IMPACT FACTORJAMA Impact Factor 2025

JAMA’s 2025 impact factor of 65.4 places it among the most influential general medicine journals globally. The journal’s Q1 ranking in Medicine, General & Internal reflects its central role in disseminating practice-changing clinical evidence and health policy research.

INDEXINGIndexing and Abstracting

JAMA is indexed in Science Citation Index Expanded (SCIE), MEDLINE/PubMed, Scopus, Embase, Current Contents/Clinical Medicine, and BIOSIS Previews. All research articles are deposited in PubMed Central. JAMA is also indexed in the major nursing, allied health, and global health databases ensuring comprehensive discoverability.

SCOPUSScopus CiteScore

JAMA’s Scopus CiteScore is approximately 42.5, placing it in the 99th percentile of general medicine journals. Articles published in JAMA receive an average of 25-35 citations within the first two years, with landmark clinical trials accumulating 500-2,000+ citations.

SUBJECTSubject Areas

JAMA publishes across all medical specialties and health-related disciplines:

• Internal Medicine and Primary Care
• Cardiology and Cardiovascular Medicine
• Oncology and Hematology
• Neurology and Neurosurgery
• Psychiatry and Mental Health
• Surgery and Surgical Specialties
• Pediatrics and Adolescent Medicine
• Obstetrics and Gynecology
• Infectious Diseases
• Endocrinology and Metabolism
• Gastroenterology and Hepatology
• Pulmonology and Critical Care
• Nephrology and Transplantation
• Rheumatology and Immunology
• Dermatology
• Ophthalmology
• Otolaryngology
• Public Health and Health Policy
• Health Services Research
• Global Health

PUBLISHERPublisher Information

JAMA is published by the American Medical Association (AMA), the largest professional association of physicians in the United States. Founded in 1847, the AMA has played a central role in American medicine, establishing standards for medical education, ethics, and practice. The JAMA Network, which includes JAMA and 11 specialty journals, publishes over 3,000 articles annually and reaches a global audience of physicians, researchers, policymakers, and healthcare professionals.

CONTACTContact and Editorial Office

OPEN ACCESSOpen Access Policy

JAMA operates a hybrid open access model. Authors may choose to make their article immediately open access for an APC of approximately $5,000 USD. Twelve months after publication, all articles become freely available through PubMed Central. JAMA participates in AMA’s institutional open access agreements with major research universities and supports NIH Public Access Policy compliance.

GUIDELINESAuthor Guidelines

JAMA publishes Original Investigations, Clinical Challenge, Clinical Reviews, Special Communications, Opinion pieces, and Letters. Original Investigations are limited to 3,500 words with up to 6 tables/figures. Clinical Reviews synthesize evidence for clinical decision-making. All submissions require structured abstracts, data sharing statements, and clinical trial registration (for trials). JAMA follows the ICMJE Recommendations and requires a completed ICMJE disclosure form from all authors.

METRICSAdditional Metrics and Rankings

SUBMISSIONSubmission and Review Process

JAMA’s editorial process begins with initial screening by editorial staff for novelty, relevance, and methodological rigor. Approximately 60% of submissions are rejected at this stage. Manuscripts selected for peer review are sent to 2-4 expert reviewers. The journal uses a single-anonymous review model. Authors receive a first decision within 14-21 days. Major revisions are common, and the editorial team provides detailed guidance to authors.

HISTORYHistory and Background

JAMA was founded in 1883 by the American Medical Association, with Nathan Smith Davis serving as the first editor. The journal grew rapidly in influence throughout the 20th century, publishing landmark studies including the first clinical trial of streptomycin for tuberculosis (1948), the Surgeon General’s report on smoking and health (1964), and numerous practice-changing clinical trials. The JAMA Network expanded in 2014 to include 11 specialty journals. In 2022, Dr. Kirsten Bibbins-Domingo became the 18th editor-in-chief and the first woman and person of color to hold the position.

ETHICSEthics and Policies

JAMA adheres to ICMJE and COPE guidelines. All clinical trials must be registered prior to patient enrollment. Authors must disclose all competing interests and complete ICMJE forms. JAMA requires data sharing statements for all clinical trials and supports data sharing through approved repositories. The journal screens all submissions for plagiarism and image manipulation. Studies involving human subjects require IRB approval and informed consent; animal studies require IACUC approval.

CITATIONCitation Trends and Analysis

JAMA is among the most cited medical journals globally, with an h5-index of approximately 385. Landmark clinical trials and guideline reviews published in JAMA routinely accumulate 1,000+ citations. The journal’s general medicine focus ensures that published research reaches a broad audience across medical specialties, public health agencies, and healthcare policy makers. JAMA articles consistently rank among the most highly cited in their respective clinical fields within the first year of publication.

FAQFrequently Asked Questions

What is the current Impact Factor of JAMA?

The 2025 Impact Factor of JAMA is 65.4, ranking Q1 in Medicine, General & Internal.

Is JAMA a Q1 journal?

Yes, JAMA is a Q1 journal in the Medicine, General & Internal category.

Who publishes JAMA?

JAMA is published by the American Medical Association (AMA).

What is the acceptance rate for JAMA?

The acceptance rate is approximately 8-12%, reflecting highly selective editorial standards.

How long does the review process take?

Authors receive a first decision within 14-21 days. Manuscripts sent for review complete the process in 4-8 weeks.

Is JAMA open access?

JAMA operates a hybrid model. Authors may choose immediate OA for ~$5,000, or articles become free after 12 months.

What types of articles does JAMA publish?

JAMA publishes Original Investigations, Clinical Challenge, Clinical Reviews, Special Communications, Opinion pieces, and Letters.

What is the word limit for Original Investigations?

Original Investigations are limited to 3,500 words with up to 6 tables or figures.